Bayer picks former Genentech CEO to replace embattled boss

Bill Anderson was CEO of Genentech from 2017 to 2019, sandwiched between two stints with parent company Roche, where he was CEO of Roche Pharmaceuticals until last month.

Previous UAB Health System eyes adding Northeast Alabama affiliate
Next St. David's Foundation pumps millions more into organizations addressing health, housing